Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
about
Analytic and clinical performance of cobas HPV testing in anal specimens from HIV-positive men who have sex with men.Human papillomavirus genotyping, human papillomavirus mRNA expression, and p16/Ki-67 cytology to detect anal cancer precursors in HIV-infected MSM.Evaluation of the Cobas 4800 HPV Test for Detecting High-Risk Human Papilloma-Virus in Cervical Cytology SpecimensPrevalence of human papillomavirus in 5,072 consecutive cervical SurePath samples evaluated with the Roche cobas HPV real-time PCR assay.A study of genotyping for management of human papillomavirus-positive, cytology-negative cervical screening resultsCervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 TestsThe Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test.Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern ThailandComparison of the Abbott RealTime High-Risk Human Papillomavirus (HPV), Roche Cobas HPV, and Hybrid Capture 2 assays to direct sequencing and genotyping of HPV DNA.Comparison of DNA testing strategies in monitoring human papillomavirus infection prevalence through simulation.Comparison of the Cobas 4800 HPV test and the Seeplex HPV4A ACE with the hybrid capture 2 testComparing the performance of six human papillomavirus tests in a screening populationStability of cervical specimens in SurePath medium for human papillomavirus testing with the Roche cobas 4800 assay.Evaluation of the clinical performance of the cobas 4800 HPV test in patients referred for colposcopyRisk factors for anal HPV infection and anal precancer in HIV-infected men who have sex with menEvaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening.Disagreement between human papillomavirus assays: an unexpected challenge for the choice of an assay in primary cervical screening.Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand.Testing and genotyping of high-risk human papillomavirus by the cobas HPV Test and the Hybrid Capture 2 high-risk HPV DNA test using cervical and vaginal samplesHybrid Capture 2 and cobas human papillomavirus assays perform similarly on SurePath samples from women with abnormalities.Comparison of the Roche Cobas® 4800 HPV assay to Roche Amplicor for detection of high-risk human papillomavirus.cobas 4800 HPV Test, a real-time polymerase chain reaction assay for the detection of human papillomavirus in cervical specimens.Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
P2860
Q34058759-45DF728F-7CA8-4273-9527-BACE815E7AC5Q34089754-0FC711E7-637D-4B88-83C4-8214AECDA433Q34533374-4DF9F4AA-D864-4222-B965-508BF86EBF0DQ34637954-82CEACE4-A239-4A2E-B4AF-81BECD557DB7Q34916671-9D547208-2D08-4E3C-ABAE-4E8F0B5CFC98Q35932079-CAD749D2-F89F-4089-B81D-C1FF8E6AF260Q36029632-C9D84602-9FBD-4F6A-929A-5B336AB1C794Q36060165-9203E39E-0D09-41F0-BE49-42CAC7B166DEQ36118559-44333CAC-2A39-4A05-909C-D6F5756A30A0Q36184620-9FB21027-6D6D-4EFD-BC20-AEA296224ACCQ36540098-FB6087AC-BB87-46A6-9E55-85BF24B9152CQ36663594-A7C02138-BADF-4BA7-9408-4960EB9D83D8Q37264271-76425D2B-53BE-4CB7-B566-3AEDC1AC7A53Q37264293-78392C9A-EB5A-4C4B-8D29-DA80ACC4FDB4Q37272349-2AFC2D1A-9271-4B69-90E5-5489361420C2Q37289143-9BB6DAD7-2B56-4F26-A0B6-A90922C3E8A2Q37496183-C8E40991-3729-49CC-A2DD-2425B5AA7322Q37560148-3A3C9CB3-D082-4880-898B-488AA49A6134Q37713689-FD37CAF0-E361-4AA0-B798-F3EA65D38D0BQ39909954-1E62F4EF-495F-4B20-91E5-C45BAED90F89Q40675275-ABC9CFE9-832C-4430-AE89-C32C1BA6913DQ42251001-4803AD6B-418D-4982-846F-A0734671DF9BQ52680864-B26FDF76-6C7C-4060-A655-5DE1B105A407
P2860
Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@ast
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@en
type
label
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@ast
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@en
prefLabel
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@ast
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@en
P2093
P2860
P356
P1476
Comparison of the cobas Human ...... nd linear array HPV DNA tests.
@en
P2093
Barbara Fetterman
Brandon J Lamere
Carrie Aldrich
Julia C Gage
Mark Sadorra
PaP Cohort Study Group
Philip E Castle
Randi Kail
Thomas Lorey
Walter Kinney
P2860
P356
10.1128/JCM.05989-11
P407
P577
2011-11-09T00:00:00Z